These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6935183)

  • 1. Basic requirements for in vitro metabolic activation systems in mutagenesis testing.
    Wood AW; Bartsch H; Fishbein L; Garattini S; Gielen J; Malaveille C; Roberfroid M; Teichman B; Vesell E
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):277-94. PubMed ID: 6935183
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro metabolic activation in genotoxicity assays with mammalian cell cultures.
    Belvedere G
    Boll Chim Farm; 1985 Feb; 124(2):57-68. PubMed ID: 4015867
    [No Abstract]   [Full Text] [Related]  

  • 3. Mutagenesis assays with mammalian cells.
    Kuroki T; Abbondandolo A; Drevon C; Huberman E; Laval F
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):107-33. PubMed ID: 6935177
    [No Abstract]   [Full Text] [Related]  

  • 4. Problems associated with the metabolic activation of carcinogens and mutagens in short-term tests.
    Bartsch H
    Dev Toxicol Environ Sci; 1980; 8():133-47. PubMed ID: 7030701
    [No Abstract]   [Full Text] [Related]  

  • 5. Mutagenesis assays with bacteria.
    Davis A; Devoret R; Green M; Hofnung M; Kawachi T; Matsushima T; McCann J; Mohn GR; Norpoth K; Radman M; Rosenkranz HS; Venitt S
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):85-106. PubMed ID: 6450174
    [No Abstract]   [Full Text] [Related]  

  • 6. [Metabolic activation systems used in short-term tests for the detection of environmental carcinogens].
    Mizgirev IV; Khudoleĭ VV
    Eksp Onkol; 1985; 7(2):15-9. PubMed ID: 4006843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategy for genotoxicity testing--metabolic considerations.
    Ku WW; Bigger A; Brambilla G; Glatt H; Gocke E; Guzzie PJ; Hakura A; Honma M; Martus HJ; Obach RS; Roberts S;
    Mutat Res; 2007 Feb; 627(1):59-77. PubMed ID: 17141553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of mammalian metabolism into mutagenicity testing.
    Malling HV
    Mutat Res; 2004 May; 566(3):183-9. PubMed ID: 15082236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenesis assays with yeasts and moulds.
    Loprieno N; von Borstel RC; Herrera L; de Serres FJ
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):135-55. PubMed ID: 6450173
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic activation of carcinogens.
    Wade AE; Dharwadkar S
    Prog Clin Biol Res; 1986; 222():587-606. PubMed ID: 3097658
    [No Abstract]   [Full Text] [Related]  

  • 11. Short-term assays to predict carcinogenicity. Metabolic activation.
    Venitt S; Bartsch H; Becking G; Fuchs RP; Hofnung M; Malaveille C; Matsushima T; Mendelsohn ML; Pegg AE; Roberfroid M
    IARC Sci Publ; 1986; (83):439-55. PubMed ID: 3305349
    [No Abstract]   [Full Text] [Related]  

  • 12. Standardization of conditions for the metabolic activation of N-nitrosodiethylamine in mutagenicity tests.
    Aiub CA; Pinto LF; Felzenszwalb I
    Genet Mol Res; 2004 Jun; 3(2):264-72. PubMed ID: 15266397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods for analysis of the mutagenicity of indirect mutagens/carcinogens in eukaryotic cells.
    Madle S; Obe G
    Hum Genet; 1980; 56(1):7-20. PubMed ID: 7009387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of microsomal and cytosolic fractions from rat, mouse, and hamster liver on the mutagenicity of dimethylnitrosamine in the Salmonella plate incorporation assay.
    Prival MJ; Mitchell VD
    Cancer Res; 1981 Nov; 41(11 Pt 1):4361-7. PubMed ID: 7030474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limitations of metabolic activation systems used in short-term tests for carcinogens.
    Bigger CA; Dipple A
    Dev Toxicol Environ Sci; 1980; 8():171-4. PubMed ID: 6796372
    [No Abstract]   [Full Text] [Related]  

  • 16. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
    Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
    Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vivo and in vitro studies of mutagenic properties of carcinogenic N-nitramines].
    Khudoleĭ VV; Malaveille C; Bartsch H
    Vopr Onkol; 1981; 27(11):59-62. PubMed ID: 7039103
    [No Abstract]   [Full Text] [Related]  

  • 18. The screening, diagnosis and evaluation of genotoxic agents with batteries of bacterial tests.
    Quillardet P; Hofnung M
    Mutat Res; 1988; 205(1-4):107-18. PubMed ID: 3285183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale for deployment of short-term assays for evidence of carcinogenicity.
    Drake JW; de Serres FJ; Darby WJ; Dunkel VC; Longfellow DG; Ott H; Purchase IF; Ramel C; Schlatter C; Smith EM
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):295-308. PubMed ID: 6935184
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.